The Weight Came Off.
The Shape Didn't.
Why women on Ozempic, Wegovy, and Mounjaro are adding a second protocol when the scale stops moving but the mirror still has work to do.
It stopped working.
Not all at once.
But somewhere around month four, the number on the scale just stopped. Your appetite is still managed. You are still doing everything right. And the lower belly, the hips, that pocket of softness along your inner thighs? Unmoved.
You did not skip doses. You did not abandon your protocol. You followed it exactly, and it delivered, right up until it didn't.
That is not a failure on your part. It is your biology doing exactly what it was designed to do. And it has nothing to do with your dose, your discipline, or your GLP-1. It has to do with which fat cells your medication can actually reach.
GLP-1s changed your relationship with food. That part worked.
But appetite suppression and fat metabolism are two completely different biological systems.
Your GLP-1 changed how much you eat. It never touched how your body accesses what is already stored.
The fat that stays after months of consistent protocol adherence is not ordinary fat. It is structurally resistant, concentrated in areas with fewer beta-3 adrenergic receptors: the receptors responsible for breaking down stored tissue. Lower abdomen. Inner thighs. Hips. These are the areas where caloric deficit has the least mechanical leverage, regardless of how disciplined you are.
AOD-9604: The Second System
The reason has a name. Beta-3 adrenergic receptors. These are the receptors responsible for mobilizing stored fat, and they are distributed unevenly across the body. Your abdomen, inner thighs, and hips have fewer of them. Caloric deficit cannot overcome receptor density. That is not a willpower problem. It is an architecture problem.
AOD-9604 was engineered specifically to activate those receptors. It is a modified fragment of human growth hormone, the 176-191 amino acid sequence, isolated to do one thing: stimulate lipolysis (the breakdown of stored fat) and inhibit lipogenesis (the creation of new fat cells).
Unlike full growth hormone, it does not elevate IGF-1 levels. It does not affect blood sugar. It does not alter insulin sensitivity. The fragment was designed to be precise, not powerful.
Your GLP-1 controls appetite. AOD-9604 activates the receptors your GLP-1 cannot reach. Two systems. Two mechanisms. One protocol.
Reduces appetite through GLP-1 receptor signaling. Controls how much you eat.
Activates beta-3 adrenergic receptors directly. Mobilizes stored fat your GLP-1 cannot access.
GLP-1 receptor agonism, gastric motility modulation
HGH fragment 176-191, direct lipolytic action on adipose tissue
Overeating, cravings, caloric surplus
Receptor-resistant stored fat, body composition plateau
Here is the data. No editorializing.
In standalone clinical trials, AOD-9604 produced modest results. Roughly 2.6 kg of fat loss versus 0.8 kg in the placebo group over 12 weeks. Real, but not dramatic.
That is the point. AOD-9604 was never designed to be a primary protocol. It was designed to sharpen one. The women reporting the strongest results are those who layer it into an existing GLP-1 regimen alongside consistent strength training and solid nutrition.
The safety profile is clean. Well tolerated across more than 900 trial participants with no meaningful impact on blood sugar, insulin sensitivity, or IGF-1 levels.
Our position: We would rather you trust us with an honest number than buy based on inflated expectations. This is a refinement protocol. For the right candidate, refinement is the only thing that has been missing.
If you just read the real numbers and you are still here, you already know this is for you.
Versus 0.8 kg in the placebo group over 12 weeks. Modest as a standalone. Significant when layered onto an existing GLP-1 regimen.
No meaningful impact on blood sugar, insulin sensitivity, or IGF-1 levels. No significant adverse events reported.
Entirely separate mechanism. Works on fat cell receptors directly. Does not compete with or diminish your existing protocol.
AOD-9604
2MG/ML. Subcutaneous injection. 8 to 12 week cycle.
Modified fragment of human growth hormone (176-191) targeting stored fat through direct lipolytic action. Stimulates fat breakdown. Inhibits new fat cell formation.
- AOD-9604 (2mg/ml), if approved
- Provider-led protocol review
- Dosing schedule + injection guide
- Syringes and supplies
- Cold-shipped express delivery
All patients must complete a provider-led health review before any medication is prescribed or dispensed. If you are not approved, you receive a full refund. AOD-9604 is not FDA-approved as a weight loss drug. All protocols are administered under direct medical supervision.
This protocol is not for everyone. That is by design.
If you are looking for the next quick fix, this is not it.
If you read that list and thought, "That is exactly where I am," keep reading.
"My husband looked at me across the kitchen counter and said, 'Something's different.' He could not name it. I could. My waistline was back."
"I caught my reflection in a store window last Tuesday and did not look away. That has not happened in three years. I forgot what it felt like to actually want to be seen."
"I spend $400 a month on GLP-1s, a trainer, and supplements. This was $108 for the one piece that was actually missing from my protocol. Easiest math I have done all year."
"I have added things before that did nothing. Supplements, creams, you name it. This is the first thing I have added to my GLP-1 that I could actually see working. Not hoping. Seeing."
"Not a magic shot. More like it finished what my GLP-1 started. Between weeks 3 and 5, my progress photos started looking different. The last layer was finally moving."
"I was starting to think the plateau was just my body now. That this was as good as it was going to get. By week 6 I realized I had been wrong. That was the best feeling of the entire process."
"My husband looked at me across the kitchen counter and said, 'Something's different.' He could not name it. I could. My waistline was back."
"I caught my reflection in a store window last Tuesday and did not look away. That has not happened in three years. I forgot what it felt like to actually want to be seen."
"I spend $400 a month on GLP-1s, a trainer, and supplements. This was $108 for the one piece that was actually missing from my protocol. Easiest math I have done all year."
"I have added things before that did nothing. Supplements, creams, you name it. This is the first thing I have added to my GLP-1 that I could actually see working. Not hoping. Seeing."
"Not a magic shot. More like it finished what my GLP-1 started. Between weeks 3 and 5, my progress photos started looking different. The last layer was finally moving."
"I was starting to think the plateau was just my body now. That this was as good as it was going to get. By week 6 I realized I had been wrong. That was the best feeling of the entire process."
Five minutes. That is the intake.
Brief intake covering your current GLP-1, dosage, timeline, training, and goals. Takes about five minutes.
A licensed provider reviews your full history within 24 hours and confirms whether AOD-9604 is appropriate for your regimen.
If approved, your medication, supplies, and dosing guide ship cold-packed to your door within 3 to 5 business days.
Reach your care team directly. Adjust dosing, flag concerns, ask questions. Available Monday, Wednesday, Friday, Saturday.
"When a patient comes to me four or five months into a GLP-1 and says the scale has stalled, the first thing I tell them is that appetite management has done its job. Body composition is now its own conversation. AOD-9604 lets me address composition directly through a mechanism that does not interfere with their existing regimen. For the right patient, it is the refinement layer that closes the gap between the scale and the mirror."
Certified Registered Nurse Anesthetist // IVUSE Clinical Provider
See If AOD-9604 Fits Your Current Regimen
This is not a checkout page. It is a protocol assessment.
You complete a brief intake covering your current medications, your goals, and your training. A provider on our team reviews everything before any recommendation is made.
Your provider tells you directly and you receive a full refund. No charge unless AOD-9604 is clinically appropriate for your protocol. The assessment itself costs you nothing.
A short intake form. Provider review within 24 hours. A personalized protocol recommendation. No upsell, no commitment until you are ready to move.
You are already investing in GLP-1 therapy, training, and nutrition. This addresses the one variable those tools were never designed to touch.
Assessment is free. Provider review within 24 hours.
You did not come this far to stop at the plateau.
Common questions. Direct answers.
No. Entirely different mechanism. Your GLP-1 works through appetite signaling and gastric motility. AOD-9604 works directly on fat cell receptors. They do not compete. They address two separate biological systems, which is precisely why the combination makes clinical sense.
Most women report visible shifts within two to three weeks. Not dramatic. More like clothes fitting differently, a trainer commenting on definition, a noticeable change in how your midsection looks at the end of the day. The full protocol runs 8 to 12 weeks. This is progressive refinement, not an overnight transformation.
AOD-9604 holds GRAS (Generally Recognized as Safe) designation and has been studied across multiple clinical trials with over 900 participants. It has not received full FDA approval as a weight loss pharmaceutical. All IVUSE protocols are administered under direct medical supervision, and your provider reviews your full history before any recommendation is made.
Minimal. Some women report mild irritation at the injection site or slight water retention in the first week. Both typically resolve on their own. Across 900+ clinical trial participants, no significant adverse events were recorded. Your provider walks you through what to expect based on your specific protocol.
AOD-9604 is available in both injectable and oral forms. If needles are not your preference, that is worth raising with your provider during the assessment. They will recommend the delivery method that makes the most sense for your protocol and your comfort level.
You receive a full refund. Your provider reviews your complete history and current regimen before making any recommendation. If AOD-9604 is not clinically appropriate for you, they will tell you directly and you will not be charged. The assessment itself is always free.